April 3, 2007
Los Angeles Times
WASHINGTON -- Drug makers spent $155 million lobbying the federal government from 2005 to mid-2006, setting a record that they could outdo this year as Congress considers high-stakes legislation for the industry and consumers, said a public interest group in a report Monday. Read more
March 27, 2007
News Channel 15
Lawmakers battled over prescription drugs on Capitol Hill Tuesday. One state lawmaker was fighting to give seniors a major price break, but drug companies countered with strong opposition.
State lawmakers examined a new way for Tennesseans to legally buy drugs from other countries, mainly Canada. The savings are amazing. Read more
March 19, 2007
Earth Times
A recent poll in Massachusetts shows that 72% of its residents want prescription drugs to be included in its new health care proposals, and would be happy to pay twenty to $40.00 extra for drug coverage. Read more
March 10, 2007
Palm Beach Post Washington Bureau
WASHINGTON – For more than two decades, Congress has been wrestling with the question of whether to allow prescription drugs to be imported from countries such as Canada, where prices are far lower than in the United States. Read more
March 8, 2007
Reuters
WASHINGTON (Reuters) - U.S. senators vowed on Wednesday to move forward with legislation to legalize the importation of cheaper prescription drugs from certain countries, despite resistance from regulators and drugmakers. Read more
March 7, 2007
Dorgan.senate.newsroom
(WASHINGTON, D.C.) --- U.S. Senator Byron Dorgan (D-ND) continued to push Wednesday to allow Americans to purchase lower-priced prescription drugs from Canada and other Western industrialized nations. Read more
March 7, 2007
Canadian Business Online
WASHINGTON (AP) – The pharmaceutical lobby pushed back Wednesday against a renewed effort in Congress to pass a law enabling U.S. consumers to buy cheaper prescription drugs from Canada and other countries. Read more
January 11, 2007
PR Newswire
A bipartisan group of lawmakers on Wednesday introduced a prescription drug reimportation bill with "high hopes for success, given the new congressional leadership and political climate on Capitol Hill," CongressDaily reports. Read more